Abstract

To investigate whether apoptin is a apoptosis-inducing protein with a potential for bladder cancer therapy. We constructed a PCDNA3/Apoptin eukaryotic expression vector, and transfected this vector into bladder cancer cell lines BIU-87 and EJ, then observed the results by RT-PCR, transmission electron microscopy, MTT assay and the flow cytometry (TUNEL method). PCDNA3/Apoptin successfully induced a high level apoptosis in both bladder cancer cell lines, compared with the controls (p<0.05). Apoptin can induce high level apoptosis in human bladder cancer EJ and BIU-87 cells, which suggests a potential for human bladder cancer therapy.

Highlights

  • Apoptin is a kind of viral protein from Chicken Anemia Virus, which can induce apoptosis in various tumor cells, but not in normal cells

  • Apoptin can induce high level apoptosis in human bladder cancer EJ and BIU-87 cells, which suggests a potential for human bladder cancer therapy

  • The plasmid PCDNA3/Apoptin was identified with double digestion of BamH I and Xho I, and sequence

Read more

Summary

Introduction

Apoptin is a kind of viral protein from Chicken Anemia Virus, which can induce apoptosis in various tumor cells, but not in normal cells. Methods: We constructed a PCDNA3/Apoptin eukaryotic expression vector, and transfected this vector into bladder cancer cell lines BIU-87 and EJ, observed the results by RT-PCR, transmission electron microscopy, MTT assay and the flow cytometry (TUNEL method).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.